Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-11 | Konstantin Konstantinov, Ph.D. Chief Technology Officer, Codiak BioSciences 65 2022 ✓ - • 59,934 84,997 255,014 399,945 |
| 2024-04-01 | Konstantin Konstantinov, Ph.D., has served as a director of Repligen since May 2022. He has also been a member of our Scientific Advisory Board since March 2016. |
| 2025-04-04 | Dr. Konstantinov received his Ph.D. in Biochemical Engineering from Osaka University, Japan, which was followed by a post-doctoral assignment at DuPont and the University of Delaware. |
Data sourced from SEC filings. Last updated: 2025-08-30